• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱饵受体3在急性细胞介导性排斥反应中抑制T细胞致敏并促进效应T细胞凋亡:反向信号传导的作用

Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling.

作者信息

Weng Shuo-Chun, Wen Mei-Chin, Hsieh Shie-Liang, Chen Nien-Jung, Tarng Der-Cherng

机构信息

Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.

Institute of Clinical Medicine, School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

出版信息

Front Immunol. 2022 Jun 2;13:879648. doi: 10.3389/fimmu.2022.879648. eCollection 2022.

DOI:10.3389/fimmu.2022.879648
PMID:35720343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9201909/
Abstract

BACKGROUND

Decoy receptor 3 (DcR3) belongs to the tumor necrosis factor (TNF) receptor superfamily and neutralizes TNF ligands, including FasL and TRAIL, to prevent T activation during T-cell priming. However, the cellular mechanisms underlying acute cell-mediated rejection (ACMR) remain unknown.

METHODS

We generated DcR3 transgenic (Tg) mice and mice with high DcR3 expression (HDE) to study both and . FasR RNA knockdown in immortalized CD4CD8 T-cells was used to survey the role of DcR3 on FasR/Fas-associated protein with death domain (FADD)/caspase 8 pathway and its cross-link to TNF receptor-associated factor 1 (TNFR1)-associated death domain protein (TRADD) in suppressing TNFR1. TNF/TRADD knockout mice were used to show the importance of TNF adaptor protein.

RESULTS

DcR3.Fc suppressed C57BL/6 female T-cell activation and transformation into CD4CD69, CD4CD44, and CD4CD25Foxp3 when compared with isotype IgG1 and its co-treatment with FasL/TRAIL after exposing to bone marrow-derived dendritic cells (BMDCs) that carried alloantigen with male H-Y and minor antigenic determinant. Interleukin-17 and interferon-γ productions by BMDC-activated T-cells were lowered after co-treating with DcR3.Fc. DcR3.Fc induced effector T-cells (Teffs) and was susceptible to FasR-mediated apoptosis through the FADD/TRADD/caspase 8 pathway. After exposing to DcR3.Fc, TRADD was silenced, likely turning down the inflammatory response. The systemic effects of DcR3 Tg mice and HDE phenotype induced by the promoter of cytomegalovirus not only attenuated ACMR severity but also ameliorated the high serum creatinine and blood urea nitrogen levels even with high T-cell exposure frequencies. Besides this, DcR3 has minor biological effects on both MHC-matched and MHC-mismatched models.

CONCLUSIONS

High DcR3 doses protect renal tubular epithelial cells from acute T-cell attack during the T-cell priming stage interfering with TNF ligand-mediated reverse signaling and possibly promoting Teff apoptosis through FasR upregulation. Our findings supported that the decoy receptor is involved in T-cell modulation in kidney transplant rejection.

摘要

背景

诱饵受体3(DcR3)属于肿瘤坏死因子(TNF)受体超家族,可中和包括FasL和TRAIL在内的TNF配体,以防止T细胞启动过程中的T细胞活化。然而,急性细胞介导的排斥反应(ACMR)的细胞机制仍不清楚。

方法

我们制备了DcR3转基因(Tg)小鼠和高DcR3表达(HDE)小鼠,以研究两者。使用永生化CD4CD8 T细胞中的FasR RNA敲低来研究DcR3在FasR/死亡结构域相关蛋白Fas相关蛋白(FADD)/半胱天冬酶8途径中的作用及其与TNF受体相关因子1(TNFR1)相关死亡结构域蛋白(TRADD)在抑制TNFR1中的交联。使用TNF/TRADD基因敲除小鼠来证明TNF衔接蛋白的重要性。

结果

与同型IgG1相比,DcR3.Fc在暴露于携带雄性H-Y和次要抗原决定簇的同种异体抗原的骨髓来源树突状细胞(BMDC)后,抑制了C57BL/6雌性T细胞活化并转化为CD4CD69、CD4CD44和CD4CD25Foxp3,以及它与FasL/TRAIL的联合处理。与DcR3.Fc联合处理后,BMDC激活的T细胞产生的白细胞介素-17和干扰素-γ减少。DcR3.Fc诱导效应T细胞(Teffs),并通过FADD/TRADD/半胱天冬酶8途径易受FasR介导的凋亡影响。暴露于DcR3.Fc后,TRADD沉默,可能降低了炎症反应。由巨细胞病毒启动子诱导的DcR3 Tg小鼠和HDE表型的全身效应不仅减轻了ACMR的严重程度,而且即使在高T细胞暴露频率下也改善了高血清肌酐和血尿素氮水平。除此之外,DcR3对MHC匹配和MHC不匹配模型均有轻微的生物学效应。

结论

高剂量的DcR3在T细胞启动阶段保护肾小管上皮细胞免受急性T细胞攻击,干扰TNF配体介导的反向信号传导,并可能通过上调FasR促进Teff凋亡。我们的研究结果支持诱饵受体参与肾移植排斥反应中的T细胞调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/df730c97e54c/fimmu-13-879648-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/48c4a953a8ac/fimmu-13-879648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/29ab256094da/fimmu-13-879648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/4a3d7a19bcae/fimmu-13-879648-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/fb8993a4d8e9/fimmu-13-879648-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/86e3c8ecee01/fimmu-13-879648-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/21e33e965759/fimmu-13-879648-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/fbc036e70c59/fimmu-13-879648-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/df730c97e54c/fimmu-13-879648-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/48c4a953a8ac/fimmu-13-879648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/29ab256094da/fimmu-13-879648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/4a3d7a19bcae/fimmu-13-879648-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/fb8993a4d8e9/fimmu-13-879648-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/86e3c8ecee01/fimmu-13-879648-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/21e33e965759/fimmu-13-879648-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/fbc036e70c59/fimmu-13-879648-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aafe/9201909/df730c97e54c/fimmu-13-879648-g008.jpg

相似文献

1
Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling.诱饵受体3在急性细胞介导性排斥反应中抑制T细胞致敏并促进效应T细胞凋亡:反向信号传导的作用
Front Immunol. 2022 Jun 2;13:879648. doi: 10.3389/fimmu.2022.879648. eCollection 2022.
2
Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.诱饵受体3:癌症生长和炎症反应中的内源性免疫调节剂
J Biomed Sci. 2017 Jun 19;24(1):39. doi: 10.1186/s12929-017-0347-7.
3
Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3).诱饵受体3(DcR3)诱导的树突状细胞凋亡
Blood. 2008 Feb 1;111(3):1480-8. doi: 10.1182/blood-2007-09-114850. Epub 2007 Nov 15.
4
Role of prognostic biomarker decoy receptor 3 and immunomodulation in kidney diseases.预后生物标志物诱饵受体 3 的作用及其在肾脏疾病中的免疫调节作用。
J Chin Med Assoc. 2019 Sep;82(9):680-684. doi: 10.1097/JCMA.0000000000000149.
5
Decoy receptor 3 suppresses TLR2-mediated B cell activation by targeting NF-κB.诱饵受体 3 通过靶向 NF-κB 抑制 TLR2 介导的 B 细胞活化。
J Immunol. 2012 Jun 15;188(12):5867-76. doi: 10.4049/jimmunol.1102516. Epub 2012 May 11.
6
Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.诱饵受体3对非肥胖糖尿病小鼠骨髓来源树突状细胞分化及功能的免疫调节作用:从调控机制到临床意义
J Leukoc Biol. 2004 Feb;75(2):293-306. doi: 10.1189/jlb.0303119. Epub 2003 Nov 21.
7
Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.类风湿性滑膜成纤维细胞中表达的诱饵受体3可保护细胞免受Fas诱导的凋亡。
Arthritis Rheum. 2007 Apr;56(4):1067-75. doi: 10.1002/art.22494.
8
Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.诱饵受体 3:炎症性疾病、自身免疫性疾病和癌症的多效性免疫调节剂和生物标志物。
Biochem Pharmacol. 2011 Apr 1;81(7):838-47. doi: 10.1016/j.bcp.2011.01.011. Epub 2011 Feb 2.
9
The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.诱饵受体3(DcR3,肿瘤坏死因子受体超家族成员6B)可抑制辅助性T细胞17(Th17)免疫反应,且在人脑脊液中含量丰富。
J Neuroimmunol. 2009 Apr 30;209(1-2):57-64. doi: 10.1016/j.jneuroim.2009.01.024. Epub 2009 Mar 6.
10
Attenuation of Th1 response in decoy receptor 3 transgenic mice.诱饵受体3转基因小鼠中Th1反应的减弱
J Immunol. 2005 Oct 15;175(8):5135-45. doi: 10.4049/jimmunol.175.8.5135.

引用本文的文献

1
[Inhibitory effect of 5-hydroxy-6,7-dimethoxyflavone on H1N1 influenza virus-induced ferroptosis and inflammation in A549 cells and its possible mechanisms].[5-羟基-6,7-二甲氧基黄酮对甲型H1N1流感病毒诱导的A549细胞铁死亡和炎症的抑制作用及其可能机制]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jun 20;44(6):1070-1078. doi: 10.12122/j.issn.1673-4254.2024.06.07.
2
Emerging strategies for treating autoimmune disease with genetically modified dendritic cells.用基因修饰树突状细胞治疗自身免疫性疾病的新策略。
Cell Commun Signal. 2024 May 7;22(1):262. doi: 10.1186/s12964-024-01641-7.
3
Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis.

本文引用的文献

1
Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury.Caspase-3 是缺血再灌注损伤后微血管稀疏和肾纤维化的关键调节因子。
J Am Soc Nephrol. 2018 Jul;29(7):1900-1916. doi: 10.1681/ASN.2017050581. Epub 2018 Jun 20.
2
Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.诱饵受体3:癌症生长和炎症反应中的内源性免疫调节剂
J Biomed Sci. 2017 Jun 19;24(1):39. doi: 10.1186/s12929-017-0347-7.
3
Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications.
DcR3 在脓毒症诊治中研究进展。
Int J Mol Sci. 2023 Aug 18;24(16):12916. doi: 10.3390/ijms241612916.
4
The dual role of the CD95 and CD95L signaling pathway in glioblastoma.CD95 及其配体信号通路在胶质母细胞瘤中的双重作用。
Front Immunol. 2022 Nov 24;13:1029737. doi: 10.3389/fimmu.2022.1029737. eCollection 2022.
终末期肾病患者中性粒细胞骨髓来源的抑制细胞的扩增可能导致感染性并发症。
Kidney Int. 2017 May;91(5):1236-1242. doi: 10.1016/j.kint.2016.12.015. Epub 2017 Feb 16.
4
Expression of decoy receptor 3 in kidneys is associated with allograft survival after kidney transplant rejection.肾脏中诱饵受体3的表达与肾移植排斥后同种异体移植物存活相关。
Sci Rep. 2015 Sep 3;5:12769. doi: 10.1038/srep12769.
5
Subcapsular transplantation of tissue in the kidney.肾脏内组织的被膜下移植
Cold Spring Harb Protoc. 2014 Jul 1;2014(7):737-40. doi: 10.1101/pdb.prot078089.
6
Challenges and advances in the treatment of AKI.急性肾损伤治疗中的挑战与进展
J Am Soc Nephrol. 2014 May;25(5):877-83. doi: 10.1681/ASN.2013070780. Epub 2014 Jan 30.
7
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.班夫 2013 年会议报告:包含 C4d 阴性抗体介导的排斥反应和抗体相关的动脉病变。
Am J Transplant. 2014 Feb;14(2):272-83. doi: 10.1111/ajt.12590.
8
Reduction of decoy receptor 3 enhances TRAIL-mediated apoptosis in pancreatic cancer.下调诱饵受体 3 可增强 TRAIL 介导的胰腺癌细胞凋亡。
PLoS One. 2013 Oct 25;8(10):e74272. doi: 10.1371/journal.pone.0074272. eCollection 2013.
9
Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages.诱饵受体 3 通过诱导肿瘤相关巨噬细胞促进肿瘤进展。
J Immunol. 2012 Mar 1;188(5):2464-71. doi: 10.4049/jimmunol.1101101. Epub 2012 Jan 27.
10
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.早期 T 细胞前体急性淋巴细胞白血病的遗传基础。
Nature. 2012 Jan 11;481(7380):157-63. doi: 10.1038/nature10725.